跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 621 条关于
“QT-019C”
全部
621
临床试验
437
药物
101
机构
1
资讯
82
3个月前
Qihan Biotech Receives FDA IND Clearance for QT-019C Universal CAR-T Therapy Targeting Autoimmune Diseases
去年
Qihan Biotech Receives FDA Clearance for QT-019B, First Universal Dual-Target CAR-T Therapy for Refractory Lupus
去年
LQT-1213 Receives FDA Orphan Drug Designation for Long QT Syndrome Treatment
4个月前
Thryv Therapeutics Initiates Phase 2/3 Trial for Long QT Syndrome Treatment, Receives FDA Fast Track Designation
7个月前
QT Sense Secures €4M to Advance Quantum Nanodiamond Platform for Real-Time Cellular Drug Discovery
去年
Thryv Therapeutics Unveils Breakthrough SGK1 Inhibitor Data for Heart Failure and Long QT Syndrome at ESC Congress 2025
9个月前
Qihan Biotech Initiates Phase I/IIa Trial of Off-the-Shelf CAR-T Therapy for Refractory Lupus
去年
Syndax's Revuforj (revumenib) Receives FDA Approval for KM2A-Rearranged Leukemia
2年前
FDA Finalizes Guidance on Clinical Pharmacology Considerations for Antibody-Drug Conjugates
去年
Adjuvant Ribociclib Approved for HR+/HER2- Early Breast Cancer, Offering New Hope for High-Risk Patients
第 1 页,共 9 页
上一页
下一页